Search results
Reeves says she hopes CEOs see their ‘fingerprints all over’ Labour manifesto
PA Media: Money via Yahoo Finance· 2 days agoMs Reeves told the summit that Labour had “campaigned as a pro-business party, and we will govern as...
XDefiant Boss Reacts To Progression Issues, Outlines Changes, And Admits He Screwed Up
GameSpot· 1 day agoUbisoft is making some changes.
Beyond BCMA-Directed CAR T-Cell Therapy
MedPage Today· 2 days agoAlthough survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment....
Anti-Israel student protests putting ‘handbrake’ on corporate diversity spending, says MindGym
The Telegraph via Yahoo Finance· 5 days agoAnti-Israel student protests on university campuses and Ron DeSantis’s so-called war on woke have...
ASCO 2024: How to Best Use New Breast Cancer Data
Medscape· 3 days agoKevin Kalinsky and Sara Hurvitz discuss the results of awaited data in the breast cancer space presented at the 2024 ASCO Annual Meeting.
Major drug companies cap asthma medication costs at $35 per month
WESH 2 Orlando· 1 day agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face the FDA's partial clinical hold following the death of two patients.
Gateway - Quartz
Quartz· 4 days agoThe millennial-targeted Hims & Hers this week joined other telehealth platforms in offering customers a cheaper, compounded version of semaglutide, the active ingredient in popular weight loss ...
China could start building world's biggest particle collider in 2027
Nature· 6 days agoThe US$5 billion facility would be cheaper, bigger and faster to build than a similar one proposed by European scientists.
FDA Approves AstraZeneca Treatment For Advanced Endometrial Cancer - AstraZeneca (NASDAQ:AZN)
Benzinga· 6 days agoAstraZeneca plc’s AZN cancer drug, Imfinzi (durvalumab), in conjunction with standard chemotherapy,...